About CardioOncoGuides

Our Mission

Cardiovascular disease is the single leading non-cancer cause of morbidity and mortality among cancer patients and long-term cancer survivors. CardioOncoGuides was established as an open-access public health initiative to bridge the gap between oncology care and cardiology surveillance.

We provide patients, caregivers, and clinicians with evidence-based guidance to detect subclinical cardiac strain early, understand cardioprotective medications, and navigate charitable co-pay relief foundations worldwide.

What We Provide

Clinical Condition Guides: In-depth breakdowns of anthracyclines, HER2 antibodies, checkpoint inhibitor myocarditis, 5-FU coronary vasospasm, and radiation heart disease.
Interactive Risk Calculators: Baseline cardiovascular risk scoring based on the 2022 ESC/ICOS consensus guidelines.
Pharmacology Decoders: Mechanism, dosing, and randomized trial evidence for Dexrazoxane, Carvedilol, Lisinopril, Empagliflozin, and Statins.
Non-Profit Copay Directory: 100+ vetted charitable funds, medical travel grants, and patient assistance programs covering 20+ countries.
Zero-Knowledge Hospital Vault: Private local storage allowing patients to log and track their ejection fractions without cloud tracking.

Part of the OncoGuides Network

CardioOncoGuides is part of the unified OncoGuides network, alongside our specialized hubs for human oncology (cancer.oncoguides.org), autoimmune conditions (autoimmune.oncoguides.org), psycho-oncology (psycho.oncoguides.org), feline oncology (cats.oncoguides.org), and canine oncology (dogs.oncoguides.org).